1. トップページ
  2. 研究業績

研究業績

発表論文

2012

  1. Tanaka R, Komoto M, Mizuno H. Skin perfusion press measurements-potentially the technique for assessing tissue viability in the distal foot. Journal of Wound Technology. 16:6-10. 2012
  2. Tanaka R, Masuda H, Kato S, Imagawa K, Kanabuchi K, Nakashioya C, Yoshiba F, Fukui T, Kobori M, Wada M, Asahara T, Miyasaka M. Autologous G-CSF mobilized peripheral blood CD34+ cell therapy for diabetic patients with chronic non-healing ulcer. Cell Transplantation. 2012 in press
  3. Josh F, Kobe K, Tobita M, Tanaka R, Suzuki K, Ono K, Hyakusoku H and Mizuno H. Accelerated and safe proliferation of human adipose-derived stem cells in medium supplemented with human serum.J Nippon Med Sch (in press)
  4. Josh F, Tobita M, Tanaka R, Orbay H, Ogata K, Suzuki K, and Mizuno H. Concentration of PDGF-AB, BB and TGF-β1 as valuable human serum parameters in adipose-derived stem cell proliferation. J Nippon Med Sch (in press)
  5. Tanaka R, Masuda H, Arita K, Hirano R, Sukmawati, D, Fujimura S, Mizuno H, Asahara T. Quality and Quantity Culture Restore Diabetic Endothelial Progenitor Cell Dysfunction for wound healing. Circulation (Suppl. 21):126,2012
  6. Masuda H, Tanaka R, Fujimura S, Akimaru H, Shizuno T. Horii M, Ishikawa M, Obi S, Kawamoto A, Asahara T. Development of Serum-Free Suspension Culture System of Peripheral Blood Mononuclear Cells to Potentiate Vascular Regeneration. Circulation. (Suppl 21) 126.2012
  7. Ervinna N, Mita T, Yasunari E, Azuma K, Tanaka R, Fujimura S, Sukmawati D, Nomiyama T, Kanazawa A, Kawamori R, Fujitani Y, Watada H: Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice. Endocrinology 2013;154:1260-1270
  8. 田中里佳. 分担)糖尿病性潰瘍患者に対する末梢血血管内皮前駆細胞移植:課題と将来の展望「幹細胞技術の標準化:再生治療への期待」. 編集:田中,正躬. 2012.10 日本規格協会.
  9. 水野 博司, 田中里佳【形成外科領域における体性幹細胞・前駆細胞の臨床応用】 幹細胞と増殖因子の臨床応用. 形成外科(0021-5228)55巻10号 Page1091-1097(2012.10)
  10. 田中里佳【最新臨床糖尿病学 下 -糖尿病学の最新動向-】 糖尿病合併症・糖尿病関連疾患 各種糖尿病合併症の概念・成因・診断・治療 糖尿病性足病変とフットケア 糖尿病性足病変の治療 糖尿病性潰瘍患者に対する血管再生治療(細胞治療)日本臨床(0047-1852)70巻増刊5 最新臨床糖尿病学(下) Page493-498(2012.07)

2011

  1. Fukui T, Kawaguchi A, Miyasaka M, Tanaka R. Liposome encapsulated hemoglobin accelerates skin wound healing in mice. J of Artificial Organs. 2011 in press
  2. Fukui T, Kawaguchi A, Takekoshi S, Miyasaka M, Tanaka R. Liposome-encapsulated hemoglobin accelerates skin wound healing in mice. Artificial Organs. 35:187.2011
  3. Tanaka R, Imagawa K, Fukui T, Miyasaka M, Asahara, T. Efficacy of G-CSF mobilized autologous peripheral blood EPC transplant for non-healing diabetic foot patients. Plast Reconstr Surg. 127: 82. 2011.
  4. 田中里佳, 浅原孝之, 宮坂宗男. 血管内皮前駆細胞による血管再生と創傷治癒. PEPARS40巻き:75-86. 2011
  5. 田中里佳, 宮坂宗男, 浅原孝之. 糖尿病性潰瘍に対する最新治療 −血管内皮前駆細胞移植の現状と可能性. 医学のあゆみ 237: 146-150, 2011

2010

  1. Tepper OM, Carr J, Allen RJ Jr, Chang CC, Lin CD, Tanaka R, Gulpa SM, Levine JP, Saadeh PB, Warren SM. Decreased circulating progenitor cell number and failed mechanisums of stromal cell-derived factor-1alpha medicated bone marrow mobilization impair diabetic tissue repair. Diabetes. Aug; 59(8):1974-83. 2010
  2. Tanaka R, Muneo M, Asahara T. Clinical Application of Autologous Endothelial Progenitor Cell Therapy for Diabetic Foot Ulcers. Journal of Wound Healing Techonology. 111-115. 2010
  3. 田中里佳, 浅原孝之, 宮坂宗男. 糖尿病性潰瘍に対する末梢血血管幹細胞治療. PEPARS. 39巻:67-73.2010.
  4. 田中里佳, 宮坂宗男. 糖尿病性潰瘍患者, 虚血性潰瘍患者を形成外科に紹介するときのコツ. 治療. 92巻. 1190-1195.2010.

2009

  1. Tanaka R, Masuda H, Miyasaka M, et al. The Biological Activity of Circulating Endothelial Progenitor Cell (EPC) is the Putative Key Factor to Determine the Efficacy of Autologous G-CSF mobilized EPC Therapy for Diabetic Patients with Chronic Non Healing Ulcer .Plast Reconstr Surg. 120:59. 2009.
  2. 田中里佳, 浅原孝之. 糖尿病血管再生療法. からだの科学. 261巻:166-170. 2009
  3. 田中里佳, 浅原孝之. 糖尿病カレントライブラリー. 10巻:95-100.2009.

2008

  1. Tanaka R, Wada M, Kwon S, Masuda H, Carr J, Ito R, Miyasaka M, Warren SM, Asahara T, Tepper OM. The Effects of Flap Ischemia on Normal and Diabetic Progenitor Cell Funnction. Plast Reconstr Surg. 121(6). 1929-42. 2008.
  2. Lin D Clarence, Allori A Alexander, Tanaka R et al. Topical Lineage- Negative Progenitor Cell Therapy for Diabetic Wounds. Plast Reconstr Surg. 122(5)1341-51. 2008.
  3. Miyasaka M, Tanaka R, Ushio H et al. A Case of Chronic Infection 28 years after SiliconOrbital Implant. Tokai J. Exp. Clin Med. 33(1):35-38. 2008
  4. Miyasaka M, Akamatsu T, Yamazaki A, Tanaka R. Clinical Experience of Bone Anchored Hearing Aid. A Case Report. Tokai J. Exp. Clin Med. 33(1):17-20. 2008.
  5. Miyasaka M, Akamatsu T, Yamazaki A, Tanaka R. A New Device for Fixing the Premaxilla with Osteotomy in a Child with Complete Bilateral Cleft Lip and Palate in the Mixed Dentition Period. A Preliminary Case Reprot. Tokai J. Exp. Clin Med. 33(1):17-20. 2008.
  6. 田中里佳, 浅原孝之. 血管内皮前駆細胞と再生医療. 循環器専門医. 16巻1号:5-11.2008.

2007

  1. Tanaka R, Wada M, Kwon S, et al Adoptive Enodothelial Progenitor Cell Therapy to Restore Vasculogenesis and Heal Diabetic Wounds. Plast Reconstr Surg. 120:59. 2007.
  2. Masuda H, Tanaka R, Yoshida M, et al. Establishment of a Novel Hierarchical Cologenic Assay Identifies Unique Population of Endothelial Progenitor Cells. Plast Reconstru Surg. 120:70. 2007
  3. Masuda H, Takahashi T, Tanaka R, Kato S, Takayuki A. Estrogen Mediated Endothelial Progenitor Cell Biology and Kinetics For Physiological Postnatal Vasculogenesis. Circ Res. 101:598-606,2007
  4. 田中里佳, 今川孝太郎, 備前篤, 福井剛志, 宮坂宗男. 糖尿病性潰瘍に対するリポプロスタグランジンE1間欠投与の効果. Skin Surgery. 2007;16(3)